Is there any relationship between expressions of minor blood group antigens with HTLV-I infection?

Transfusion and Apheresis Science

Volumn 47, Issue 2, 2012, Pages 151-154

  Sadeghian, Mohammad Hadi ^a   Keramati, Mohammad Reza ^b   Ayatollahi, Hossein ^c   Feizabadi, Atefeh Shirinzadeh ^d   Tehranaian, Farahnaz ^e   Shakibyee, Hossein ^e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Imamreza Hospital   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Faculty of Medicine   (Iran)

^e Blood Transfusion Center of Khorasan Razavi   (Iran)

Author keywords

Blood group; HTLV I; Virus

Indexed keywords

BLOOD GROUP ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE;

ADOLESCENT; ADULT; BLOOD GROUP ANTIGENS; CASE-CONTROL STUDIES; HTLV-I INFECTIONS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865409230     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.06.012     Document Type: Article

References (28)

1. Mahieux R., Gessain A. Adult T-cell leukemia/lymphoma and HTLV-I. Curr Hematol Malig Rep 2007, 2:257-264.
2. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
3. Keramati M.R., Sadeghian M.H., Ayatollahi H. Clinical and laboratory features in adult T-cell leukemia/lymphoma in Khorasan, Iran. Leuk Lymphoma 2010 Apr, 51(4):727-729.
4. Ayatollahi H., Rafatpanah H., Khayyami M.E., Sayyadpour D., Ravarian M., Sadeghian M.H., et al. Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran. AIDS Res Hum Retroviruses 2008, 24:1155-1158.
5. Tarhini M., Kchour G., Zanjani D.S., Rafatpanah H., Otrock Z.K., Bazarbachi A., et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology 2009, 41(5):498-499.
6. Caskey M.F., Morgan D.J., Porto A.F., Giozza S.P., Muniz A.L., Orge G.O., et al. Clinical manifestations associated with HTLV type I infection: a cross-sectional study. AIDS Res Hum Retroviruses 2007 Mar, 23(3):365-371.
7. Beadling W.V. Immunohematology. Henry's clinical diagnosis and management by laboratory methods 2007, 621-638. Elsevier Saunders, Pennsylvania. 21th ed. R.A. McPherson, M.R. Pincus (Eds.).
8. Calhoun L., Petz L.D. Erythrocyte antigens and antibodies. Williams hematology 2010, 1843-1859. McGRAW-HILL, New York. 8th ed. K. Kaushansky, M. Lichtman, E. Beutler, T. Kipps, J. Parchal, U. Seligsohn (Eds.).
9. Anstee D.J. The relationship between blood groups and disease. Blood 2010, 115(23):4635-4643.
10. Nakao M., Matsuo K., Hosono S., Ogata S., Ito H., Watanabe M., et al. ABO blood group alleles and the risk of pancreatic cancer in Japanese population. Cancer Sci 2011, 102(5):1076-1080.
11. Behal R., Jain R., Behal K.K., Dhole T.N. Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection. Epidemiol Infect 2010, 138(8):1096-1099.
12. Hennig E.E., Mernaugh R., Edl J., Cao P., Cover T.L. Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect Immun 2004, 72(6):3429-3435.
13. Yamaoka Y. Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol 2008, 14(27):4265-4272.
14. Moran A.P. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr Res 2008, 343(12):1952-1965.
15. González-Ordóñez A.J. Blood groups and disease. Med Clin (Barc) 2005, 125(10):382-388.
16. Miyoshi M., Yoshizumi S., Sato C., Okui T., Ogawa H., Honma H. Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study. Kansenshogaku Zasshi 2005, 79(9):664-671.
17. He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008, 4(1):52-62.
18. Sadeghian M.H., Keramati M.R., Badiei Z., et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci 2009, 3:95-98.
19. Branch D.R. Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol 2010, 17(6):558-564.
20. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005, 26(2):27.
21. Kinet S., Swainson L., Lavanya M., Mongellaz C., Montel-Hagen A., Craveiro M., et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 2007, 15(4):31.
22. Jones K.S., Fugo K., Petrow-Sadowski C., Huang Y., Bertolette D.C., Lisinski I., et al. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol 2006, 80(17):8291-8302.
23. Takenouchi N., Jones K.S., Lisinski I., Fugo K., Yao K., Cushman S.W., et al. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol 2007, 81:1506-1510.
24. Neil S.J., McKnight A., Gustafsson K., Weiss R.A. HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood 2005, 105(12):4693-4699.
25. Winkler C.A., An P., Johnson R., Nelson G.W., Kirk G. Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans. Cell Host Microbe 2009, 5(5):411-413. [author reply 418-9].
26. Lachgar A., Jaureguiberry G., Le Buenac H., Bizzini B., Zagury J.F., Rappaport J., et al. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother 1998, 52(10):436-439.
27. Kulkarni H., Marconi V.C., He W., Landrum M.L., Okulicz J.F., Delmar J., et al. The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood 2009, 114(13):2783-2792.
28. Ukaejiofo E.O., Nubila T. Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria. West Afr J Med 2006, 25(1):61-64.